Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models

BackgroundThe polyherbal eye drop (Itone™) is a mixture of aqueous distillates of nineteen traditionally used ingredients that sum up to impart potency to the formulation and make it a useful adjunct in various ocular pathologies. However, as there have been no controlled experimental studies accounting to the above claim, therefore, the present study was designed to evaluate the polyherbal formulation (PHF) for antiangiogenic, anti-inflammatory, anticataract, antioxidant and cytotoxicity in addition to the evaluation of intraocular penetration of PHF in rabbit eyes using LC-MS/MS.Materials and methodsAntiangiogenic activity of the PHF was evaluated using in ovo chick chorio-allantoic membrane (CAM) assay and in vivo cautery induced corneal neovascularization assay in rats. Anticataract potential was evaluated using steroid induced cataract in developing chick embryos, sodium selenite induced cataract in rat pups and galactose induced cataract in rats. The antioxidant activity was evaluated using di-phenyl picryl hydrazyl (DPPH) radical scavenging assay. Anti-inflammatory activity was evaluated in vitro using inhibition of LTB4 formation in human WBCs and in vivo using carrageenan induced paw edema assay in rats. The cytotoxicity was evaluated against HeLa cancer cell lines using (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Furthermore evaluation of the intraocular penetration of the PHF was carried out in rabbit eyes via aqueous humor paracentesis and further analysis using LC-MS/MS.ResultsPHF significantly inhibited VEGF induced proliferation of new blood vessels in CAM assay and inhibited the cautery induced corneal neovascularization in rats. Additionally, PHF showed noticeable delay in the progression of cataract in the selenite and galactose induced cataract models whereby the PHF treated lenses were graded for stages II and III respectively. However, the PHF did not show any anticataract activity in the hydrocortisone induced cataract model. Moreover, PHF exhibited anti-inflammatory activity whereby it showed 39.34% inhibition of LTB4 formation and significantly inhibited carrageenan induced paw edema in rats. Eight compounds of PHF viz. camphor, casticin, curcumin-II, quercetin, rosmarinic acid, γ-terpinene, β-pinene and dipentene exhibited transcorneal penetration in rabbit eyes.ConclusionThe significant antiangiogenic and anti-inflammatory activities evinced by the PHF merits further investigation for ocular neovascular and inflammatory diseases in humans.

[1]  I. Dubé.  [Ocular irritation]. , 1973, La Vie medicale au Canada francais.

[2]  N. Lagali,et al.  Cellular level characterization of capillary regression in inflammatory angiogenesis using an in vivo corneal model , 2011, Angiogenesis.

[3]  Ivana Oštádalová,et al.  Cataract induced by administration of a single dose of sodium selenite to suckling rats , 1978, Experientia.

[4]  R. Roskoski,et al.  Vascular endothelial growth factor (VEGF) signaling in tumor progression. , 2007, Critical reviews in oncology/hematology.

[5]  Horst Spielmann,et al.  12 – Ocular Irritation , 1996 .

[6]  L. Aiello,et al.  Angiogenesis and ophthalmic disease , 2004, Angiogenesis.

[7]  A Vacca,et al.  New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. , 1997, Journal of vascular research.

[8]  K. Ohuchi,et al.  The content of prostaglandin E and prostaglandin F2alpha in the exudate of carrageenin granuloma of rats. , 1976, Biochimica et biophysica acta.

[9]  P. Suryanarayana,et al.  Effect of curcumin on galactose-induced cataractogenesis in rats. , 2003, Molecular vision.

[10]  M. S. Blois,et al.  Antioxidant Determinations by the Use of a Stable Free Radical , 1958, Nature.

[11]  J. W. Miller.  Vascular endothelial growth factor and ocular neovascularization. , 1997, The American journal of pathology.

[12]  J. Castell,et al.  In vitro methods in pharmaceutical research , 1997 .

[13]  P. Hogan,et al.  Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[14]  N R Biswas,et al.  Comparative double blind multicentric randomised placebo controlled clinical trial of a herbal preparation of eye drops in some ocular ailments. , 1996, Journal of the Indian Medical Association.

[15]  N. Biswas,et al.  Comparative randomised controlled clinical trial of a herbal eye drop with artificial tear and placebo in computer vision syndrome. , 2003, Journal of the Indian Medical Association.

[16]  A. Sckell,et al.  The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice , 2006, BMC Cancer.

[17]  C A WINTER,et al.  Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  N. Sheibani,et al.  Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.

[19]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[20]  J. Arbiser,et al.  Curcumin Is an In Vivo Inhibitor of Angiogenesis , 1998, Molecular medicine.

[21]  H. Nishigori.  [Steroid (glucocorticoid)-induced cataract]. , 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[22]  L. Waterbury,et al.  Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. , 1985, Current eye research.

[23]  T. Ciulla,et al.  Corticosteroids as antiangiogenic agents. , 2006, Ophthalmology clinics of North America.

[24]  D. Azar,et al.  Corneal neovascularization. , 2001, Current opinion in ophthalmology.

[25]  S. Gupta,et al.  Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. , 2006, Journal of ethnopharmacology.

[26]  H. Kaplan,et al.  Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis. , 2006, Investigative ophthalmology & visual science.

[27]  H. Nishigori,et al.  An animal model for cataract research: cataract formation in developing chick embryo by glucocorticoid. , 1983, Experimental eye research.

[28]  秀夫 西郡.  鶏胚を用いたグルココルチコイド作用・副作用の研究 —白内障の発症機序から治療効果を残した予防を考える— , 2006 .

[29]  T. Velpandian,et al.  Evaluation of calcium dobesilate for its anti-cataract potential in experimental animal models. , 2010, Methods and findings in experimental and clinical pharmacology.

[30]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[31]  S. S. Agrawal,et al.  Advances in pharmacological strategies for the prevention of cataract development , 2009, Indian journal of ophthalmology.

[32]  N P Luepke,et al.  Hen's egg chorioallantoic membrane test for irritation potential. , 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[33]  S. Park,et al.  Biotechnological applications for rosmarinic acid production in plant , 2008 .

[34]  T. Sippel,et al.  Changes in the water, protein, and glutathione contents of the lens in the course of galactose cataract development in rats. , 1966, Investigative ophthalmology.